Get Started with ixamBee
Start learning 50% faster. Sign in now
The USFDA has issued a form 483 with 10 observations after inspection of Sun Pharma's Halol facility. The unit, however, now has a low contribution to the company’s turnover. The Halol facility was classified ‘Official Action Indicated (OAI)’ in March 2020, and was awaiting re-inspection from the US regulator. Due to the pandemic related travel restrictions, the re-inspection got delayed, and now the USFDA has issued a form 483 with observations. Sun Pharma said that the US Food and Drugs Administration (USFDA) did a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Halol facility in Gujarat from April 26 to May 9, 2022. The Company is preparing the response to the observations, which will be submitted to the US FDA within 15 business days.
A combination of erosion permitting and resistive crops in alternate rows are constructed perpendicular to the direction of wind and water flow, to pre...
The 3rd day of the 5 days training program for designated Officer focuses on:
____________ is a cumbu hybrid rice in fe content.
The Certificate of Export (COE) is issued by APEDA for the export of _____
Which stage does adulteration take place in ?
In tea, which one of the following insecticides does not cause resurgence of pink mite.
Synaptonemal complex develops during which stage of Meiosis?
In periodic table, Helium is placed at-
Among the following soil types, which one demonstrates the highest infiltration rate, indicating the soil's ability to allow water to permeate easily?
Which one of the following describes a system of agriculture where a single crop is grown on a large area?
